| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Bahrt Kenneth is a Chief Medical Officer at Outlook Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 2 sells.
Estimated insider holdings value: $74K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2018 | OTLK Outlook Therapeutics, Inc. | Chief Medical Officer | Sell | 7,700 | $0.85 | $6,507.27 | -14.0% | |
| Dec 22, 2017 | OTLK Outlook Therapeutics, Inc. | Chief Medical Officer | Sell | 26,165 | $1.13 | $29,566.45 | -32.3% | |
| May 13, 2016 | OTLK Outlook Therapeutics, Inc. | Chief Medical Officer | Buy | 2,000 | $0.00 | - | New |